150 related articles for article (PubMed ID: 27478411)
1. PADI2 gene confers susceptibility to breast cancer and plays tumorigenic role via ACSL4, BINC3 and CA9 signaling.
Wang H; Xu B; Zhang X; Zheng Y; Zhao Y; Chang X
Cancer Cell Int; 2016; 16():61. PubMed ID: 27478411
[TBL] [Abstract][Full Text] [Related]
2. Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.
Guo W; Zheng Y; Xu B; Ma F; Li C; Zhang X; Wang Y; Chang X
Onco Targets Ther; 2017; 10():1475-1485. PubMed ID: 28331341
[TBL] [Abstract][Full Text] [Related]
3. PADI2 is significantly associated with rheumatoid arthritis.
Chang X; Xia Y; Pan J; Meng Q; Zhao Y; Yan X
PLoS One; 2013; 8(12):e81259. PubMed ID: 24339914
[TBL] [Abstract][Full Text] [Related]
4. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
5. Protein-arginine deiminase 2 suppresses proliferation of colon cancer cells through protein citrullination.
Funayama R; Taniguchi H; Mizuma M; Fujishima F; Kobayashi M; Ohnuma S; Unno M; Nakayama K
Cancer Sci; 2017 Apr; 108(4):713-718. PubMed ID: 28403548
[TBL] [Abstract][Full Text] [Related]
6. PADI4 has genetic susceptibility to gastric carcinoma and upregulates CXCR2, KRT14 and TNF-α expression levels.
Zheng Y; Zhao G; Xu B; Liu C; Li C; Zhang X; Chang X
Oncotarget; 2016 Sep; 7(38):62159-62176. PubMed ID: 27556695
[TBL] [Abstract][Full Text] [Related]
7. PADI2-Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1-Mediated SOX2 mRNA Stability in Endometrial Cancer.
Xue T; Liu X; Zhang M; E Q; Liu S; Zou M; Li Y; Ma Z; Han Y; Thompson P; Zhang X
Adv Sci (Weinh); 2021 Mar; 8(6):2002831. PubMed ID: 33747724
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine deiminase 2 promotes T helper 17-like T cell activation and activated T cell-autonomous death (ACAD) through an endoplasmic reticulum stress and autophagy coupling mechanism.
Yang YF; Wang CM; Hsiao IH; Liu YL; Lin WH; Lin CL; Hung HC; Liu GY
Cell Mol Biol Lett; 2022 Mar; 27(1):19. PubMed ID: 35236296
[TBL] [Abstract][Full Text] [Related]
9. Peptidylarginine deiminase 2 plays a key role in osteogenesis by enhancing RUNX2 stability through citrullination.
Kim HJ; Shin HR; Yoon H; Park MS; Kim BG; Moon JI; Kim WJ; Park SG; Kim KT; Kim HN; Choi JY; Ryoo HM
Cell Death Dis; 2023 Aug; 14(8):576. PubMed ID: 37648716
[TBL] [Abstract][Full Text] [Related]
10. Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells.
Hsu PC; Liao YF; Lin CL; Lin WH; Liu GY; Hung HC
Mol Cells; 2014 May; 37(5):426-34. PubMed ID: 24850148
[TBL] [Abstract][Full Text] [Related]
11. PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.
Wang L; Song G; Zhang X; Feng T; Pan J; Chen W; Yang M; Bai X; Pang Y; Yu J; Han J; Han B
Cancer Res; 2017 Nov; 77(21):5755-5768. PubMed ID: 28819028
[TBL] [Abstract][Full Text] [Related]
12. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
[TBL] [Abstract][Full Text] [Related]
13. Peptidyl Arginine Deiminase, Type II (PADI2) Is Involved in Urothelial Bladder Cancer.
Gao BS; Rong CS; Xu HM; Sun T; Hou J; Xu Y
Pathol Oncol Res; 2020 Apr; 26(2):1279-1285. PubMed ID: 31267364
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer.
Lin HY; Yu CC; Chi CL; Wei CK; Yin WY; Tseng CE; Li SC
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627159
[TBL] [Abstract][Full Text] [Related]
15. The role of peptidylarginine deiminase 4 in ovarian cancer cell tumorigenesis and invasion.
Cui YY; Yan L; Zhou J; Zhao S; Zheng YB; Sun BH; Lv HT; Rong FN; Chang XT
Tumour Biol; 2016 Apr; 37(4):5375-83. PubMed ID: 26563365
[TBL] [Abstract][Full Text] [Related]
16. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
17. The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
Nagai T; Matsueda Y; Tomita T; Yoshikawa H; Hirohata S
Clin Exp Rheumatol; 2018; 36(2):248-253. PubMed ID: 29148420
[TBL] [Abstract][Full Text] [Related]
18. Protein citrullination as a source of cancer neoantigens.
Katayama H; Kobayashi M; Irajizad E; Sevillarno A; Patel N; Mao X; Rusling L; Vykoukal J; Cai Y; Hsiao F; Yu CY; Long J; Liu J; Esteva F; Fahrmann J; Hanash S
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34112737
[TBL] [Abstract][Full Text] [Related]
19. CA1 contributes to microcalcification and tumourigenesis in breast cancer.
Zheng Y; Xu B; Zhao Y; Gu H; Li C; Wang Y; Chang X
BMC Cancer; 2015 Oct; 15():679. PubMed ID: 26459317
[TBL] [Abstract][Full Text] [Related]
20. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
Ye X; Zhang Y; Wang X; Li Y; Gao Y
IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
